Search

everythinglearnresearchcommunity

for

Search:↓

A sick foal with Rhodococcus equi pneumonia was successfully treated for multiple complications with targeted therapy and careful monitoring.

Daprodustat, combined with PAβN, could be a new antibacterial treatment.

Upadacitinib can cause hypersensitivity that worsens ulcerative colitis symptoms.

Cepharanthine may help treat gastric cancer by causing cancer cell death and affecting energy use.

Colchicine can inhibit hair growth by affecting cell activity and protein expression in hair follicles.

Early diagnosis and treatment are crucial for CAPS, and Eculizumab can be effective.

A protein called PCBP2 controls the production of a hair growth protein by interacting with its genetic message and is linked to hair loss when this control is disrupted.

Cepharanthine can potentially treat gastric cancer by stopping tumor growth.

Certain genetic variations are linked to higher liver enzyme levels in patients treated for chronic hepatitis C with specific drugs.

ICP5249 helps hair grow by activating a specific cell pathway.

Budesonide and N-acetylcysteine reduced tumors and alopecia in mice, regardless of FHIT gene status.

The study concludes that certain domains in Clostridium histolyticum enzymes are structurally unique, bind calcium to become more stable, and play distinct roles in breaking down collagen, with potential applications in medicine and drug delivery.

A certain medication improved severe itching in a boy with liver and bowel disease by reducing histamine levels, suggesting a new treatment target.

HAIRCARECUBE TM (HCC) helps hair products work better by getting active ingredients deeper into the hair.

UHP-sCESr is as effective as HESr for treating BPH symptoms.

A new microneedle patch significantly improves melanoma treatment by using a special material to activate cancer-fighting drugs and disrupt cancer cells.

A man developed skin issues from cancer medication, which improved with specific treatments.

Cepharanthine may help treat COVID-19 by targeting similar pathways as other inflammatory diseases.

Epirubicin is as effective as doxorubicin for cancer treatment with less heart damage, but doesn't work on doxorubicin-resistant cancers.

Baricitinib and its combination with lonafarnib improve fat cell formation in certain genetic disorders.

Single-dose parenteral iron is safe and effective for children with inflammatory bowel disease and iron-deficiency anemia.

Cathelicidins could treat skin issues but face challenges like safety and resistance.

Diphencyprone initially increases mouse hair growth, then slows it, possibly due to changes in specific protein levels.

A man lost all his hair after stopping hepatitis C treatment and it didn't grow back.

CD101 is highly effective in treating dermatophytosis in guinea pigs.

The new palladium catalyst is effective and reusable for making pharmaceutical ingredients.

GCN reduces lung inflammation and damage from air pollution in mice.